Article
Tissular glucocorticoid reactivating enzyme 11beta-HSD1 drives pathogenic myofibroblast…
medRxiv · 2025 · Arnoux, G.; Legouis, D.; Tihy, M.; Yvon, R.; Liaudet, N.; Moser, S.; Poinot, H.; SASSI, A.; Lempke, O.; Fernandez, M.; Monnay, I.; Chassot, A.; Bourquin, C.; Moll, S.; Somm, E.; Rutkowski, J. M.; Wenger, R. H.; Naesens, M.; Odermatt, A.; Nlandu Khodo, S.; Pommier, A.; Feraille, E.
Key facts
| Title | Tissular glucocorticoid reactivating enzyme 11beta-HSD1 drives pathogenic myofibroblast differentiation in chronic kidney disease |
|---|---|
| First author | Arnoux, G.; Legouis, D.; Tihy, M.; Yvon, R.; Liaudet, N.; Moser, S.; Poinot, H.; SASSI, A.; Lempke, O.; Fernandez, M.; Monnay, I.; Chassot, A.; Bourquin, C.; Moll, S.; Somm, E.; Rutkowski, J. M.; Wenger, R. H.; Naesens, M.; Odermatt, A.; Nlandu Khodo, S.; Pommier, A.; Feraille, E. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.01.09.631985 |
| Devices mentioned | K110035 |
| Product codes mentioned | JJE, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1